Clinical Trial: The Use of DHEA in Women With Premature Ovarian Failure

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: The Use of DHEA in Women With Premature Ovarian Failure

Brief Summary: DHEA supplementation has been used in women with infertility and diminished ovarian reserve. There is a small report in 5 women with POF that benefited from the use of DHEA over several months. The investigators aim to evaluate further the use of DHEA in women with Premature ovarian failure (POF).

Detailed Summary:
Sponsor: Virginia Center for Reproductive Medicine

Current Primary Outcome: The Use of DHEA in Women With Premature Ovarian Failure [ Time Frame: 3 years ]

The following outcomes will be evaluated: FSH, AMH, estradiol, ovarian volume, antral follicle count, pregnancy in women seeking to conceive


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Virginia Center for Reproductive Medicine

Dates:
Date Received: May 23, 2010
Date Started: May 2010
Date Completion:
Last Updated: January 26, 2013
Last Verified: January 2013